Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IST:SELEC'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.25 Med: 0.37 Max: 0.47
Current: 0.35
During the past 13 years, the highest Equity to Asset Ratio of Selcuk Ecza Deposu Ticaret venayi AS was 0.47. The lowest was 0.25. And the median was 0.37.
IST:SELEC's Equity-to-Asset is ranked worse than 56.67% of 120
companies
in the Medical Distribution industry
Industry Median: 0.39
vs IST:SELEC: 0.35
Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Selcuk Ecza Deposu Ticaret venayi AS Equity-to-Asset Related Terms
Selcuk Ecza Deposu Ticaret venayi AS Equity-to-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Selcuk Ecza Deposu Ticaret venayi AS Equity-to-Asset Chart
IST:SELEC vs MCK, COR, CAH: Equity-to-Asset Comparison
For the Medical Distribution subindustry, Selcuk Ecza Deposu Ticaret venayi AS's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Selcuk Ecza Deposu Ticaret venayi AS Equity-to-Asset vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Selcuk Ecza Deposu Ticaret venayi AS's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Selcuk Ecza Deposu Ticaret venayi AS's Equity-to-Asset falls into.
Selcuk Ecza Deposu Ticaret venayi AS Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) has a Equity-to-Asset of 0.35 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Selcuk Ecza Deposu Ticaret venayi AS and its competitors. This is near median its historical median of 0.37. Over the past decade, Selcuk Ecza Deposu Ticaret venayi AS's Equity-to-Asset has ranged from 0.25 to 0.47. According to the industry distribution chart, Selcuk Ecza Deposu Ticaret venayi AS ranks #68 out of 120 companies in the Medical Distribution industry, placing it in the top 56.7%.
Is Selcuk Ecza Deposu Ticaret venayi AS's Equity-to-Asset too high?
Selcuk Ecza Deposu Ticaret venayi AS's current Equity-to-Asset of 0.35 is near median its 10-year median of 0.37. Over the past 10 years, this metric has ranged from a low of 0.25 to a high of 0.47. The Medical Distribution industry median Equity-to-Asset is 0.39. Selcuk Ecza Deposu Ticaret venayi AS's value of 0.35 is 10.3% below this industry median. Based on the distribution chart, Selcuk Ecza Deposu Ticaret venayi AS ranks #68 out of 120 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Selcuk Ecza Deposu Ticaret venayi AS has a GF Score™ of 80/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Selcuk Ecza Deposu Ticaret venayi AS's Equity-to-Asset compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Selcuk Ecza Deposu Ticaret venayi AS ranks #68 out of 120 companies for Equity-to-Asset. This places Selcuk Ecza Deposu Ticaret venayi AS in the lower half of its industry. The industry median Equity-to-Asset is 0.39. Selcuk Ecza Deposu Ticaret venayi AS's value of 0.35 is 10.3% below this benchmark. Historically, Selcuk Ecza Deposu Ticaret venayi AS's own Equity-to-Asset has ranged from 0.25 to 0.47 over the past decade. While the company's 10-year median is 0.37 vs. the industry median of 0.39, Selcuk Ecza Deposu Ticaret venayi AS has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Distribution company?
The median Equity-to-Asset among Medical Distribution companies is 0.39, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Selcuk Ecza Deposu Ticaret venayi AS's current Equity-to-Asset of 0.35 is 10.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Selcuk Ecza Deposu Ticaret venayi AS and its competitors. For the Medical Distribution industry, the median Equity-to-Asset is 0.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Selcuk Ecza Deposu Ticaret venayi AS's current Equity-to-Asset is 0.35, which is near median its own 10-year median of 0.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Selcuk Ecza Deposu Ticaret venayi AS stock overvalued right now?
Based on GuruFocus' analysis, Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) is currently considered Significantly Overvalued. The stock's GF Value™ is ₺91.95, compared to a current price of ₺251.00 — trading 173% above its estimated fair value. The current Equity-to-Asset is 0.35, which is near median its 10-year median of 0.37 and 10.3% below the Medical Distribution industry median of 0.39. Selcuk Ecza Deposu Ticaret venayi AS's overall GF Score™ is 80/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC), the current Equity-to-Asset is 0.35 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) Overvalued in 2026?
Based on GuruFocus' analysis, Selcuk Ecza Deposu Ticaret venayi AS stock appears to be overvalued.
The current stock price of ₺251.00 is trading 173% above its estimated GF Value™ of ₺91.95.
GuruFocus considers Selcuk Ecza Deposu Ticaret venayi AS to be Significantly Overvalued.
Key valuation signals for IST:SELEC:
Equity-to-Asset: 0.35 (near median its 10-year median of 0.37)
GF Value™: ₺91.95 vs. price of ₺251.00 (173% above fair value)
Industry Position: 10.3% below the Medical Distribution median (#68 of 120)
No single metric tells the full story. See the IST:SELEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Selcuk Ecza Deposu Ticaret ve Sanayi AS and its subsidiaries are in the business of export and import of drugs and patent medicines, medical supplies with pharmacy depot operations and also organize distribution channels between drug manufacturers, hospitals, and pharmacies. The company also distributes cosmetics, personal care, infant food, vitamins, medical and similar products.
80GF Score
Get the complete analysis for IST:SELEC
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:SELEC has been successfully added to your 
